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Abstract
Background: Classical strains of Salmonella enterica serovar Typhimurium (Typhimurium) predominantly cause a
self-limiting diarrheal illness in humans and a systemic disease in mice. In this study, we report the characterization
of a strain isolated from a blood-culture taken from a 15-year old woman suffering from invasive severe
salmonellosis, refractory to conventional therapy with extended-spectrum cephalosporin (ESC).
Results: The strain, named 33676, was characterized as multidrug-resistant Salmonella serogroup A by biochemical,
antimicrobial and serological tests. Multilocus sequence typing (MLST) and XbaI macrorestrictions (PFGE) showed
that strain 33676 belonged to the Typhimurium ST213 genotype, previously described for other Mexican
Typhimurium strains. PCR analyses revealed the presence of IncA/C, IncFIIA and ColE1-like plasmids and the
absence of the Salmonella virulence plasmid (pSTV). Conjugation assays showed that the ESC-resistance gene
blaCMY-2 was carried on the conjugative IncF plasmid, instead of the IncA/C plasmid, as found in previously studied
ST213 strains. Although the IncA/C plasmid conferred most of the observed antimicrobial resistances it was not
self-conjugative; it was rather able to conjugate by co-integrating with the IncF plasmid. Strain 33676 was fully
attenuated for virulence in BALB/c mice infections. Both type-three secretion system (T3SS), encoded in Salmonella
pathogenicity islands 1 and 2 (SPI-1 and SPI-2), were functional in the 33676 strain and, interestingly, this strain
produced the H2 FljB flagellin instead of the H1 FliC flagellin commonly expressed by S. enterica strains.
Conclusions: Strain 33676 showed two main features that differentiate it from the originally described ST213
strains: 1) the blaCMY-2 gene was not carried on the IncA/C plasmid, but on a conjugative IncF plasmid, which may
open a new route of dissemination for this ESC-resistance gene, and 2) it expresses the H2 FljB flagella, in contrast
with the other ST213 and most Typhimurium reference strains. To our knowledge this is the first report of an IncF
blaCMY-2-carrying plasmid in Salmonella.
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Background
Salmonella enterica are Gram-negative flagellated bac-
teria that cause salmonellosis, a food-borne disease in
humans causing gastroenteritis and bacteremia world-
wide. The most prevalent Salmonella serovars isolated
from humans and other animals are Typhimurium and
Enteritidis [1, 2]. Typhimurium strains cause gastro-
enteritis in humans and several animals, whereas in mice
they produce a systemic infection similar to the enteric
fever generated by the human-restricted serovar Typhi
[3, 4]. In most S. enterica serovars, the antigenic formula
is composed by two flagellar phases (H1 and H2). That
is, Salmonella can express two different flagellin sub-
units, FliC and FljB, from two divergently oriented
genes. The expression of FliC and FljB is controlled by
phase variation, which involves the inversion of a 1 kb
DNA containing the promoter of fljB, to express either
fljB or fliC genes [5]. Commonly, the S. enterica strains
express the flagellar H1 phase. Although the role of fla-
gella in motility, chemotaxis and pathogenesis is recog-
nized, the biological significance of phase variation in
Salmonella has been scarcely addressed [3, 6].
The majority of Salmonella virulence genes are clustered
in regions distributed over the chromosome called Salmon-
ella pathogenicity islands (SPIs), whereas others are found
on the Salmonella virulence plasmid (pSTV) [7–10]. More
than twenty SPIs have been described for Salmonella [11];
however, the well-studied are SPI-1 and SPI-2. Both SPI-1
and SPI-2 contain around 40 genes that encode a type-
three secretion system (T3SS), which mediate the trans-
location of effector proteins into the eukaryotic host cells.
The T3SS and effector proteins encoded in SPI-1 are ne-
cessary for Salmonella invasion of intestinal epithelial cells,
and thus for the intestinal colonization leading to enteritis;
whereas the T3SS and effector proteins encoded in SPI-2
are mainly required for Salmonella survival and replication
inside macrophages, and hence for the systemic disease
[3, 8]. The pSTV plasmid belongs to the F incompati-
bility group (IncF), harboring the spv operon, which is
necessary to confer full virulence in mice [12–14]; how-
ever, the role of this plasmid in human infections is less
clear. It has been accepted that pSTV is not required to
cause gastroenteritis, but its association with human
bacteremia is still in debate [12, 15, 16].
Antimicrobial resistance among Salmonella has been
increasing, particularly in serovar Typhimurium [1].
Antimicrobial therapy is not required for most Salmon-
ella infections, but it may be lifesaving in patients with
or at risk for extra-intestinal infection [17]. Several stud-
ies have addressed the increased risk for hospitalization,
invasive illness, and death posed by multi-drug resistant
(MDR) Salmonella [18–20].
In Mexico, the results of an integrated food chain sur-
veillance program showed that Typhimurium was the
serovar most frequently associated with human infec-
tions, and particularly high MDR levels were recorded in
both humans and food-animals [21]. Zaidi et al. reported
the emergence of MDR Typhimurium strains with
extended-spectrum cephalosporin (ESC) resistance in
Yucatán, as the cause of severe enteric and systemic in-
fections in children [22]. The ESC-resistance was found
to be determined by the blaCMY-2 gene, which confers
resistance to ceftriaxone (CRO), the antibiotic of choice
for treating severe gastroenteritis and systemic infec-
tions. In a previous study, we analyzed a sample of 114
Typhimurium strains from the surveillance program in
Mexico by multi-locus sequence typing (MLST), macro-
restrictions (PFGE), and PCR typing for accessory genes
involved in virulence and anti-microbial resistance [23].
We found that all the MDR strains with the ESC-
resistant phenotype carried the blaCMY-2gene on a large
plasmid (150 kb) of the IncA/C incompatibility group
(IncA/C), and that these strains belonged to a new
chromosomal multi-locus genotype, designated in the
MLST database as sequence type 213 (ST213) [23, 24].
Another distinctive feature of the ST213 genotype was
the lack of the pSTV, which contains virulence determi-
nants and is characteristic of serovar Typhimurium,
which was nevertheless present in strains with other ge-
notypes in the Mexican population, such as ST19,
ST302 and ST429 [23].
In this work we studied a Salmonella strain, named
33676, isolated from a blood-culture taken from a 15-year
old young woman suffering a febrile illness with invasive
severe pancolitis, refractory to conventional therapy with
ESC. The aim of the study was to characterize genetic and
phenotypic attributes of strain 33676, to get insights on
the biology behind the unusual severe clinical manifesta-
tions observed in a patient with no signs of malnutrition,
immunodeficiency or other underlying medical condi-
tions. A battery of molecular and phenotypic approaches
were applied to analyze strain 33676, including MLST,
PFGE, PCR detection of plasmid markers, along with anti-
microbial susceptibility tests, protein secretion profiles,
and assays for virulence in the murine host. The useful-
ness of these molecular and phenotypic typing methods in
the detection and classification of Salmonella strains, and
in the context of host adaptation and the current epi-
demiological situation is discussed.
Methods
Ethics statement
Since this is a retrospective case-report of a patient
cared during routine clinical practice on May 2011, no
written or informed consent was obtained. Laboratory
studies were part of the routine diagnostic work-out in a
patient with diarrhea and a fever. There was no submis-
sion to an institutional review board (ethics committee)
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at the hospital, as this report did not imply the implemen-
tation and conductance of a designed research protocol
with human participants. Blood and stool samples were
collected by laboratory technicians of the hospital, as part
of the routine clinical care of the patient. The unit of study
in the present communication was a bacterial strain, iso-
lated from this patient, which was characterized in a re-
search laboratory. Microbiologists carrying out this task
coded this bacterial strain omitting any disclosure of the
patient’s identity.
The studies performed with animals were carried out
in strict accordance with the recommendations in the
guide for the Care and Use of Laboratory Animals of the
National Institutes of Health, USA. The protocol was
approved by the Committee on the Ethics of Animal
Experiments of the Instituto de Biotecnología de la
UNAM, Mexico (Permit Number: 286). Animals were
sacrificed before signs of suffering appeared.
Strain isolation, antimicrobial susceptibility tests, and
serological classification
The bacterial strain described in this report was isolated
from a previously healthy 15-year old young woman
who attended the emergency room of a private hospital
in Mexico City, with a 4-day duration clinical picture
characterized by fever, vomiting, severe abdominal pain
and watery bloody diarrhea. The patient was started with
amoxicillin/clavulanic acid medication 72 h before hos-
pital admission. Upon clinical examination, one gram of
intravenous ceftriaxone every 12 h was commenced. At
day 4, due to the adverse clinical course of the disease,
and based on the report of the antibiotic susceptibility
tests for the bacterium (Salmonella) isolated from stool
and blood cultures (see below), ceftriaxone was changed
to ertapenem. Clinical improvement 24 h after this
therapeutic modification was observed. At day 9, the
patient was discharged from the hospital with complete
remission of all systemic and abdominal signs and
symptoms.
The microbiological investigation of stool and blood
samples was performed at the Instituto Nacional de
Ciencias Médicas y de la Nutrición Salvador Zubirán,
using the VITEK-2 AST-115 panel (bioMerieux), which
allows microbial identification of bacteria and antibiotic
susceptibility by the broth microdilution method accord-
ing to Clinical and Laboratory Standards Institute [25].
The biochemical tests showed that both samples con-
tained Salmonella. The serogroup determination was
performed with Salmonella O antisera (Difco), used in
slide agglutination tests for the identification of Salmon-
ella by somatic (O) antigens. The flagellar antigen H was
not assessed. For further studies, the strain isolated from
the blood-culture was named as 33676 (Table 1).
DNA extraction, MLST and PFGE
Genomic DNA was extracted using standard laboratory
protocols [26]. PCR amplifications were performed using
Taq DNA polymerase (Invitrogen, Brazil), and the prod-
ucts were purified with a purification kit from Qiagen
(Valencia, California, USA), and submitted for sequen-
cing at Macrogen (Seoul, South Korea).
The seven loci used in the S. enterica MLST scheme
were aroC, dnaN, hemD, hisD, purE, sucA and thrA [27].
The PCR primers and conditions used were those re-
ported in the MLST web site (http://mlst.warwick.ac.uk/
mlst/dbs/Senterica). The sequences at each locus were
submitted to the web database for allele assignment, and
the combination of alleles was assigned to a sequence
type (ST).
The restriction of genomic DNA with XbaI was re-
solved by pulsed-field gel electrophoresis (PFGE) using
the standardized protocol from PulsNet CDC [28]. The
XbaI restriction patterns were clustered using the un-
weighted pair-group method with arithmetic averages.
The analysis was performed with GelComparII using
band matching and Dice coefficients with a 1.5 % band
position tolerance.
PCR detection of plasmids, virulence and antimicrobial-
resistance genes
We determined by PCR the presence of plasmids of the
incompatibility groups IncA/C, ColE1-like, IncFIIA,
IncHI2, IncI1 and IncX, which are among the most
frequently reported to carry antimicrobial resistance in
enteric bacteria [29]. Three regions previously used as
markers for the IncA/C plasmids were amplified: blaCMY-2,
conferring resistance to ESC; floR, conferring resistance to
chloramphenicol; and the 2 kb class 1 integron (dfrA12,
orfF and aadA2), conferring resistance to trimethoprim
and streptomycin [23, 24]. Three regions distributed along
the pSTV were detected as well by PCR: rck, spvC and
traT, involved in resistance to serum and survival in mac-
rophages [12, 13, 30]. To detect the presence of the genes
encoding flagellar subunits FliC and FljB, PCR amplifica-
tion were performed for fliC and fljB genes. The PCR con-
ditions were those previously reported [23, 24], and the
Table 1 Bacterial strains used in this study
Strain Features Reference
33676 Typhimurium human invasive ST213 strain This study
YU39 Typhimurium human invasive ST213 strain [31]
SL1344 Typhimurium ST19 reference strain [62]
ΔssrB SL1344 derivative, ΔssrB::kan, strain MJW112 [63]
ΔSPI-1 SL1344 derivative, ΔSPI-1::kan [64]
ΔSPI-2 SL1344 derivative, ΔSPI-2::kan [65]
DH5α E. coli laboratory strain [26]
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primers used are listed in Additional file 1: Table S1.
Primers used in this study.
DNA plasmid extraction was performed by the alka-
line lysis procedure as reported elsewhere [23, 26], and
plasmids were visualized by electrophoresis in 0.7 %
agarose gels subjected to 60 V for 8 h.
Conjugation and transformation experiments
To determine the transfer capabilities of the plasmid car-
rying the blaCMY-2 gene, conjugation experiments were
performed as previously reported [24, 31]. A spontaneous
rifampicin-resistant mutant of the nalidixic acid-resistant
Escherichia coli DH5α strain was used as recipient
(Table 1), and transconjugants were selected on rifampicin
(100 μg/ml), nalidixic acid (60 μg/ml) and ceftriaxone
(CRO) (2 μg/ml). Transfer frequencies were calculated as
the number of transconjugants per donor. The conjuga-
tion experiments were repeated three times.
To obtain transformants with the different plasmids of
strain 33676, the alkaline lysis plasmid extraction was used
as donor DNA to electroporate competent DH5α strains.
Ceftriaxone (2 μg/ml), tetracycline (12 μg/ml) and chlor-
amphenicol (60 μg/ml), separately, were used for selection
of transformants. Transformant colonies were analyzed by
PCR with primers for the IncFIIA and IncA/C incompati-
bility groups (Additional file 1: Table S1. Primers used in
this study) as described above.
Competitive index (CI) assays for mice virulence
Mice infections and calculation of the competitive index
(CI) were performed as described previously [32, 33].
Briefly, five BALB/c mice were infected orally with an
equal mix of 104 bacteria of SL1344 standard reference
strain and test strains. The test strains were the two Mexi-
can Typhimurium strains isolated from human invasive
infections, 33676 or YU39, and the ΔssrB::kan SL1344 de-
rivative strain lacking the SsrB regulator necessary for the
expression of SPI-2 genes (Table 1). After three days of in-
fection, animals were sacrificed by CO2 asphyxiation
followed by cervical dislocation, and the bacterial load in
the spleen and liver was quantified from organ homoge-
nates by plating serial 10-fold dilutions of cell lysates on
LB agar plates and counting the colony-forming units
(CFUs) for each strain. Ampicillin resistance of 33676 and
YU39, as well as kanamycin resistance of ΔssrB, were used
to differentiate these strains from SL1344, which is not re-
sistant to these antibiotics. The CI was calculated as the
ratio 33676/SL1344, YU39/SL1344 or ΔssrB/SL1344 of
CFUs obtained from the mouse organs, divided by their
respective ratio from the initial inoculum [33].
Protein secretion analysis and flagella characterization
Analysis of the proteins secreted by the type III secretion
systems encoded in SPI-1 and SPI-2 was performed as
described previously [34]. Secretion mediated by SPI-1
and SPI-2 was determined in bacterial cultures grown for
9 h in LB and for 16 h in N-minimal medium (N-MM) at
pH 5.8, respectively. Proteins contained in 1.5 ml samples
of culture supernatants were precipitated by the addition
of 10 % (v/v) trichloroacetic acid and overnight incubation
at 4 °C. Precipitated proteins were concentrated by centri-
fugation at 16,000 g for 30 min at 4 °C. Pellets were resus-
pended in SDS-PAGE loading buffer containing 10 %
saturated Tris base. Samples were subjected to SDS-PAGE
analysis, using 12 % polyacrylamide gels. The SPI-1-
encoded proteins SipA, SipB, SipC and SipD, as well as
the flagellar protein FliC or FljB, were detected by staining
with Coomassie Brilliant Blue R-250. The SPI-2-encoded
SseB protein was detected by Western blot with an anti-
SseB polyclonal antibody, as described previously [34].
The intense band of about 57 kDa secreted by strain
33676 was excised from the gel, digested with trypsin, and
analyzed by liquid chromatography-mass spectrometry at
the Unidad de Proteómica of the Instituto de Biotecnolo-
gía, UNAM.
Results
Strain 33676 was identified as an MDR Salmonella
serogroup A 1, 4, 5 (+)
We studied a strain isolated from a patient with severe
pancolitis and bacteremia. Bacterial isolates were
obtained both from stool and blood samples. The bio-
chemical tests showed that the isolates belonged to
Salmonella. Serological classification showed that the
isolates were from the Salmonella serogroup A, factor 1,
4, 5 (+). The isolates were resistant by minimum inhibi-
tory concentrations (MICs) break-points to 12 out of 19
antimicrobials: ampicillin (MIC > =32), amoxicillin/cla-
vulanic acid (MIC > =32), ticarcillin/clavulanic acid
(MIC > =128), piperacillin/tazobactam (MIC > =128),
cefazolin (MIC > =64), ceftazidime (MIC > =64), ceftri-
axone (MIC > =64), amikacin (MIC < =2), gentamicin
(MIC > =16), ciprofloxacin (MIC =2), nitrofurantoin
(MIC = 128) and trimethoprim/sulfamethoxazole (MIC >
=320). Sensitivity was recorded to cefepime, ertapenem,
imipenem, meropenem, norfloxacin, tigecycline and
fosfomycine. Resistance to chloramphenicol (30 μg/ml),
streptomycin (100 μg/ml) and tetracycline (12 μg/ml)
was also recorded by growth in LB broth supplemented
with these antibiotics, which were later used to analyze
the conjugation ability of the strain (see below).
For further studies, the strain isolated from the blood-
culture was named as 33676. The antimicrobial suscepti-
bility tests showed that strain 33676 was MDR, which
explains the empiric therapeutic failure obtained when
the patient was treated with amoxicillin/clavulanic acid
or ceftriaxone, whereas positive response was obtained
with ertapenem, and the patients’ health was restored.
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MLST and PFGE showed that strain 33676 belongs to
Typhimurium ST213
The combination of alleles for the seven loci used in the
S. enterica MLST scheme showed that strain 33676 be-
longs to ST213, which was initially reported for Mexican
Typhimuirum strains [23], and has been recently re-
ported for other Typhimurium strains from the United
Kingdom and Netherlands (http://mlst.warwick.ac.uk/
mlst/dbs/Senterica). Achtman et al. had provided evi-
dence that MLST can be used to assign strains to Sal-
monella serovars, since the housekeeping genes used in
the MLST scheme are conserved among salmonellae and
hence reflect the evolutionary history of the strains [35].
To set strain 33676 in the context of our previously ana-
lyzed Typhimurium ST213 strains, sub-typing was per-
formed by restriction of genomic DNA with XbaI
resolved by pulsed-field gel electrophoresis (PFGE). The
comparison of the XbaI restriction profile with those of
the Mexican Typhimurium strains reported by Wiesner
et al. [23] showed that strain 33676 grouped within the
ST213 cluster (Additional file 2: Figure S1. Strain 33676
belongs to the Mexican ST213 population). Under the
evidence provided by the MLST and PFGE data, strain
33676 belongs to the Typhimurium ST213 evolutionary
lineage.
Strain 33676 carries IncA/C, IncF and ColE-1-like plasmids
The PCR screening showed that strain 33676 harbored
plasmids of incompatibility groups IncA/C, IncFIIA and
ColE1-like. The amplification of the other three IncA/C
plasmid markers, the antibiotic resistance genes blaCMY-2
and floR, and the 2 kb integron, were also positive, sug-
gesting the presence of an IncA/C plasmid carrying the
blaCMY-2 gene. PCR amplifications for three markers dis-
tinctive of the pSTV (rck, spvC and traT) were negative,
indicating that 33676 does not carry a pSTV. However,
the positive amplification with the IncFIIA primers indi-
cated that an IncF plasmid, other than pSTV, was present
in 33676. The plasmid profile of strain 33676 showed the
presence of three plasmids of about 150, 120 and 5 kb
(Fig. 1, lanes 1 and 7), which corresponded to the IncA/C,
IncF, and ColE1-like plasmids, respectively (see below).
The blaCMY-2 gene is borne on a conjugative IncF
plasmid
The mobility of the 33676 blaCMY-2 gene was studied by
conjugation assays selecting DH5α transconjugants re-
sistant to ceftriaxone. DH5α transconjugants resistant to
CRO were found at a frequency of 5.9-1.9 x 10−6. The
transconjugants were evaluated by PCR for the presence
of the repA/C, blaCMY-2 and floR markers of the IncA/C
plasmid. Unexpectedly, the transconjugants were posi-
tive only for blaCMY-2, but not for repA/C and floR
markers, indicating that blaCMY-2 was not carried on the
IncA/C plasmid. Positive amplification was recorded
with the IncFIIA primers, indicating that in strain
33676 the blaCMY-2 gene was located on a conjugative
IncF plasmid. The plasmid profile displayed by the
transconjugants revealed that the 120 kb plasmid was
the IncF plasmid carrying the blaCMY-2 gene (Fig. 1,
lane 6).
The MDR IncA/C plasmid is not conjugative but can
co-integrate with the conjugative IncF plasmid
A transformation assay was performed, using the alkaline-
lysis plasmid extract of 33676 as donor DNA, and DH5α
strain as recipient. Selection was performed with ceftriax-
one to obtain the IncF plasmid with the blaCMY-2 gene,
and with chloramphenicol or tetracycline to select for the
Fig. 1 Plasmid profiles for strain 33676 and its transformant or
transconjugant derivatives. Strain 33676 carries three plasmids of
about 150, 120 and 5 kb, corresponding to IncA/C, IncF and ColE1-
like plasmids, respectively (lanes 1 and 7). E.coli DH5α derivatives
were obtained by conjugation or transformation. Transformants were
obtained with chloramphenicol (Tf-cm, lane 2), ceftriaxone (Tf-CRO,
lane 3), and tetracycline (Tf-tc, lane 4); transconjugants were obtained
with tetracycline (Tc-tc, lane 5), and ceftriaxone (Tc-CRO, lane 6)
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IncA/C plasmid. The plasmid profiles and the PCR typing
with the IncFIIA and IncA/C primers, confirmed that the
transformant colonies obtained with ceftriaxone only car-
ried the IncF plasmid (Fig. 1, lane 3), while the colonies
obtained with chloramphenicol or tetracycline only con-
tained the IncA/C plasmid (Fig. 1, lanes 2 and 4).
The amplification products of the blaCMY-2 gene
present in the IncF plasmid transformants, and the 2 kb
integron (conferring resistance to streptomycin and tri-
methoprim/sulfamethoxazole) present in the IncA/C
plasmid transformants, were sequenced and showed nu-
cleotide sequences identical to those reported for the
other Mexican ST213 strains [23]. Antimicrobial suscep-
tibility tests for the transformant colonies showed that
the IncF plasmid accounted for resistance to penicillin
and cephalosporin antibiotics, whereas the IncA/C plas-
mid provided resistance to the other antibiotic classes
(chloramphenicol, gentamicin, streptomycin, tetracycline
and trimethoprim/sulfamethoxazole). These results indi-
cated that most of the resistance determinants were car-
ried by the MDR IncA/C plasmid, while the IncF
plasmid carried only the blaCMY-2 gene which accounts
for penicillin and cephalosporin resistances.
To determine if the IncA/C plasmid was conjugative, a
conjugation experiment was performed selecting with
tetracycline, using strain 33676 as the donor and DH5α
as the recipient strain. Transconjugant colonies were ob-
tained at a frequency of 1 x 10−5. Transconjugants were
positive for the amplification with the IncA/C primers;
however, they were also positive for amplification with
the IncF primers, indicating that both plasmids were
transferred. The plasmid profiles of the tetracycline-
resistant transconjugants displayed only one plasmid,
larger than the IncA/C plasmid (Fig. 1, lane 5). PCR am-
plifications with the blaCMY-2, floR and integron regions
were positive, and the antimicrobial resistance profiles
showed resistance to 10 out of the 15 resistances, as
found for the parental 33676 strain, suggesting that the
large plasmid was formed by the co-integration of the
complete IncA/C and IncF plasmids.
We hypothesized that the IncA/C plasmid of strain
33676 was not self-conjugative, and that co-integration
with the IncF plasmid was necessary to be transferred.
To test this hypothesis, a conjugation assay was per-
formed, using as donor a DH5α transformant strain car-
rying the IncA/C plasmid, and DH5α as recipient. No
transconjugants were obtained, supporting the notion
that the IncA/C plasmid is not self-conjugative, as previ-
ously found for the other ST213 strains [24, 31].
Strains 33676 and YU39 are fully attenuated for virulence
in BALB/c mice
Classical Typhimurium strains, such as SL1344, cause
severe systemic infections in mice [36]. To determine
whether strain 33676 displayed a similar or different
virulence phenotype in mice as compared to that of clas-
sical strains, the ability of this invasive strain to compete
with the reference strain SL1344 in colonizing the liver
and spleen of mice was tested by CI assays. For these as-
says, another ST213 strain was included, YU39, which
was isolated in 2005 in Yucatán, Mexico, from the
blood-culture of an eight-year old boy with hepatomeg-
aly and severe thrombocytopenia with hemorrhagic syn-
drome. This strain was also referred to as YUHS 05-78
in previous studies (Table 1) [23, 24]. Due to the fact
that SsrB is a transcriptional regulator required for the
expression of the Salmonella pathogenicity island 2
genes, which are essential for the intracellular prolifera-
tion of Salmonella and thus for its systemic infection in
mice [3], a ΔssrB strain derivative of SL1344 was used as
a negative control in these assays. Interestingly, after
three days of infection, strains 33676 and YU39 were
not detected or isolated from the mice organs at very
low numbers, a similar phenomenon observed for the
mutant ΔssrB strain, whereas a high number of bacteria
was detected for the wild-type strain SL1344. Therefore,
extremely low CIs values were obtained for the ratios
33676/SL1344, YU39/SL1344 and, as expected, for
ΔssrB/SL1344 (Table 2). These results indicate that
strains 33676 and YU39 are fully attenuated for systemic
infection in mice.
Strain 3376 has functional SPI-1- and SPI-2-encoded type
III secretion systems and produces the flagellar subunit
FljB
SPI-1 and SPI-2 are essential for virulence; each one en-
codes a T3SS through which Salmonella translocates ef-
fector proteins from the bacteria into the cytoplasm of
host cell [3, 4]. In order to determine the functionality of
these T3SSs, protein secretion mediated by SPI-1 and
SPI-2 was analyzed for strain 33676, as well as for the
reference strain SL1344 and for ΔSPI-1 and ΔSPI-2 mu-
tants derived from SL1344, which lack SPI-1 and SPI-2,
respectively (Table 1). Both strains 33676 and SL1344
showed the typical SPI-1-mediated protein secretion
profile (SipA, SipB, SipC and SipD proteins) and the
Table 2 Competitive indexes (CIs)a for mice infections between
the reference strain SL1344, human invasive strains 33676 and
YU39, and the SPI-2 mutant strain ΔssrB
Ratio Spleen Liver
33676/SL1344 <5 x 10−8 < 7 x 10−8
YU39/SL1344 < 5 x 10−8 < 8 x 10−7
ΔssrB /SL1344 < 8 x 10−8 < 3 x 10−8
a CI values lower than 1 indicate virulence attenuation. For most mice no
bacteria were detected for strains 33676, YU39 and ΔssrB; thus, the values
showed represent the lower detection limit for these assays
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secreted SPI-2-encoded protein SseB. As expected, these
SPI-1 or SPI-2 encoded proteins were not detected in
the respective ΔSPI-1 or ΔSPI-2 mutants (Fig. 2a and
b). Typhimurium can present phase variation to alter-
natively express two different flagellin subunit pro-
teins, FliC and FljB [37], which can be detected in
the protein secretion analysis for SPI-1. Whereas
strain SL1344 showed FliC, strain 33676 presented a
higher molecular weight protein of about 57 kDa
(Fig. 2a); which was identified by protein sequence
analysis as the flagellin subunit FljB, indicating that
strain 33676 expresses phase H2 flagella. PCR amplifi-
cations for the fliC and fljB genes from strain 33676
were positive, and product sequencing showed that
both genes were identical to those of other Typhi-
murium strains, such as DT104 (HF937208), indicat-
ing that the differential expression of fljB was not due
to the absence a fliC gene.. Therefore, these results
showed that both T3SSs are functional in strain
33676, and revealed that strain 33676 produces the
flagellar subunit FljB in the growth conditions tested,
instead the FliC phase that is common for most S.
enterica strains.
Discussion
The results of MLST along with PFGE provided unequivo-
cal evidence that this strain belonged to the ST213 geno-
type of serovar Typhimurium (Additional file 2: Figure S1.
Strain 33676 belongs to the Mexican ST213 population).
PCR typing, in combination with plasmid profiling,
allowed to discover that in strain 33676 the ESC-
resistance gene, blaCMY-2, was carried on an IncF plasmid.
This is in contrast with the previously analyzed ST213
strains, which carried this gene on IncA/C plasmids, as
found for other Typhimurium strains [24, 38]. Despite the
fact that strain 33676 indeed harbors an IncA/C plasmid,
which accounts for most of the MDR phenotype, the
blaCMY-2 gene maps to a conjugative IncF plasmid.
Although IncF plasmids have been involved in antibiotic
resistance in enteric bacteria [39–41], there is only one re-
port of an IncF plasmid carrying blaCMY-2 in E. coli [42];
however, to our knowledge this is the first report of an
IncF blaCMY-2-carrying plasmid in Salmonella.
In a previous conjugation study, with another ST213
donor strain (YU39), we found that the blaCMY-2 gene
was transferred to recipient strains by means of co-
integration with a conjugative IncX1 plasmid, or by
transposition of the blaCMY-2 region into the conjugative
IncX1 plasmid [31]. In the present study, when strain
33676 was challenged for conjugation using as selection
an antibiotic carried by the IncA/C plasmid (tetracyc-
line), chimeric plasmids containing the molecular
markers and antibiotic resistance profile of both IncA/C
and IncF plasmids were obtained. The co-integration of
the MDR IncA/C plasmid with the conjugative IncF-
blaCMY-2 carrying plasmids in strain 33676, resembles
the co-integration found among the IncA/C-blaCMY-2
plasmid and the conjugative IncX1 plasmid previously
recorded in strain YU39 [31]. In both cases, the non-
conjugative IncA/C plasmids took advantage of the con-
jugation machinery of a co-resident plasmid to transfer
their antimicrobial resistance capabilities. In fact, it is
possible to observe a faint band of the size of the co-
integrate formed by the IncF and IncA/C on the plasmid
profile of strain 33676 (Fig. 1, lanes 1 and 7), but not in
the IncA/C and IncF transformants or transconjugant
strains, supporting the notion that the co-integrate plas-
mid is naturally formed at low frequencies in the wild-
type strain, even under non-selective pressure conditions
without antibiotic. Taken together, these phenomena
highlight the plastic nature of the plasmid compartments
of the genomes of these ST213 Typhimurium strains.
In contrast to the classical Typhimurium strains, such
as SL1344, which cause gastroenteritis in humans and
systemic infection in mice, the Typhimurium ST213
strains 33676 and YU39 were isolated from human sys-
temic infections and both were fully attenuated for viru-
lence in mice (Table 2). A common feature of the ST213
Fig. 2 Strain 33676 has functional SPI-1 and SPI-2-encoded T3SSs
and secretes FljB flagellin. Analysis of secreted proteins from culture
supernatants was performed for strains SL1344, 33676 and ΔSPI-1 or
ΔSPI-2 grown in LB (a) or N-MM (b). TCA-precipitated proteins SipA,
SipB, SipC and SipD, secreted through the T3SS encoded in SPI-1 (a),
and protein SseB, secreted through the T3SS encoded in SPI-2 (b),
were detected by Coomassie blue staining and by Western blot,
respectively. FliC and FljB (a) are flagellin subunits proteins whose
secretion is independent of SPI-1
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strains is the lack of pSTV [23]. Many studies have dem-
onstrated that pSTV is necessary for full virulence in the
mouse [12, 13]. Evidence indicates that, in mice, the spv
genes enable Typhimurium strains to infect the spleen
and the liver by increasing the rate of bacterial replica-
tion within host cells. Plasmid-cured strains are able to
colonize and persist in the spleen and the liver, but bac-
terial growth is controlled by host defenses and infection
does not develop [14]. This is in agreement with the
findings of Kapperud et al. [43], which studied a large
Typhimurium outbreak traced to contaminated choc-
olate, and found that the strains lacking the pSTV were
not virulent to mice, but caused acute, hemorrhagic
diarrhea in children less than two years old [43]. Fur-
thermore, we have tested other ST213 strains (lacking
pSTV) and none of them were virulent in mice (data not
shown). Therefore, the lack of pSTV likely explains the
attenuated virulence of ST213 strains in mice. However,
chromosomal-encoded factors are also required and can
determinate differential virulence phenotype in mice of
Typhimurium strains [44]. García-Quintanilla et al. dem-
onstrated that the transfer of the pSTV from mice-
virulent strains (SL1344 and ATCC 14028) did not pro-
vide virulence in mice to the non-virulent strain LT2
cured from its pSTV [45]. Furthermore, Heithoff et al.
[46] suggested that Salmonella isolates derived from hu-
man salmonellosis patients are distinct from those of
animal (chicken, cow, dog, horse, sheep and turkey) ori-
gin. They found that a fraction (19 %) of the Typhimur-
ium strains (harboring the pSTV) derived from human
salmonellosis patients were virulent in mice, in contrast
with the virulent phenotype exhibited by all the animal
isolates (harboring pSTV) examined [46].
Previously, since we found that in the Mexican Typhi-
murium population the pSTV was significantly associated
with human isolates, and that ST213 strains lacking pSTV
caused most of the systemic infection cases and were sig-
nificantly associated with animal sources, we suggested
that pSTV could be involved in human host adaptation
[23]. However, the involvement of pSTV in human sys-
temic infections is still controversial and deserves more
research [12, 15, 16, 47]. Together, these studies indicate
that bacterial-host interactions are complex, and several
genetic elements are involved in the outcome of infection,
and, that virulence in mice cannot be directly extrapolated
to human virulence and vice versa [3, 30, 43, 47].
In addition to the defect in virulence showed by
ST213 strains in mice, our preliminary results support
the notion that strains 33676 and YU39 have a dimin-
ished ability to invade, but not to replicate within HeLa
cells (data not shown). The absence of pSTV could be
related to the invasion defect showed by 33676 and
YU39 strains, since it has been demonstrated that pSTV
is also necessary for cell invasion [4, 12, 48, 49].
The mechanisms employed by the pSTV-devoid
ST213 strains to cause systemic disease in humans open
new avenues for the study of Salmonella-host interac-
tions. In the present study, it was demonstrated that the
T3SSs from SPI-1 and SPI-2, which are essential for
Salmonella virulence, are functional in strain 33676
(Fig. 2). Furthermore, it was found that strain 33676 ex-
presses FljB flagellar subunit (Fig. 2a), which is unusual
in Typhimurium; most of the reference strains, such as
SL1344 (Fig. 2a), LT2 and 14028S express FliC flagella
[6, 37]. Flagella-based motility is required for the initial
contact of Typhimurium with epithelial cells [50]. Even
when strain 33676 expresses the FljB flagellar subunit,
instead of FliC expressed by strains SL1344 and YU39,
the motility of these three strains was similar on LB
plates containing soft agar (data not shown), which sup-
ports that a difference in motility is not involved in the
invasion defect showed by strains 33676 and YU39. In a
previous study, the effect of FljB and FliC on mice viru-
lence was determined, by constructing phase-locked de-
rivative strains [6]. The authors found that a
Typhimurium classical strain locked-ON (expressing
only FljB) was attenuated for virulence in the mouse,
and the authors concluded that the ability to switch to
the FliC phase has a selective advantage for Typhimur-
ium to survive in mice [6]. However, in this study we
found that, although the 33676 and YU39 strains express
FljB and FliC (Fig. 2a and Additional file 3: Figure
S2), respectively, they show similar virulence pheno-
types (Table 2). Therefore, the expression of FljB, in-
stead FliC, probably does not determine the virulence
attenuation of the 33676 strain in mice, but it could
be relevant for infection to humans. It has been estab-
lished that a decreased production of FliC flagella reduces
the inflammatory response [51], but the effect of FljB fla-
gella on the human immune response remains to be
studied.
ST213 was reported to be an emergent genotype in
Mexico, characterized by the lack of pSTV, and the pres-
ence of multiple-drug resistance determinants, most of
which are carried by IncA/C plasmids [23, 24]. We
alerted about the emergence of the MDR genotype ST213
in Mexico, carrying resistance to ESC, which caused six
out of the seven human systemic infections cases included
in the study [22, 23]. The finding that strain 33676
(isolated in 2011) belongs to the MDR ST213 lineage indi-
cates that this genotype continues to be a leading cause of
disease in Mexico.
Strain 33676 shared most of the features studied in the
ST213 surveillance population. However, two distinct
features distinguished the originally described ST213
strains from strain 33676. First, the blaCMY-2 gene was
not carried on the IncA/C plasmid, but on a conjugative
IncF plasmid. And second, strain 33676 expresses the
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H2 FljB flagella. The antimicrobial resistance profile of
strain 33676 increased, since ciprofloxacin resistance
was not recorded in the 2000-2005 isolates [23]. These
findings indicate that the emergent ST213 genotype is
spreading and diversifying in Mexico.
Strain 33676 caused invasive disease in a young woman
with no signs of malnutrition, immunodeficiency or other
underlying medical conditions, which is unusual; since
Salmonella systemic infections are more likely to occur in
young children, immunologically compromised patients,
and patients with comorbid medical conditions, such as
malnutrition [3, 17, 52]. Invasive MDR Typhimurium
strains have emerged as prominent cause of bloodstream
infections worldwide in the last three decades [18–20, 23,
53–56]. Recently, the Typhimurium genotype ST313 has
emerged as a new pathogen in sub-Saharan Africa, [51,
52]. ST313 is an MDR genotype characterized by harbor-
ing a version of pSTV carrying antibiotic resistance genes,
and by signs of chromosomal degradation, with a higher
number of pseudogenes as compared with other Typhi-
murium strains [55]. The ST313 genome degradation
could account for adaptation to cause invasive disease in
human beings, and also human-to-human transmission
[52]. These two features are similar to those of the
human-restricted serovar Typhi. In this respect, prelimin-
ary analysis of the complete genome of strain 33676 [57]
showed a four-fold higher number of pseudogenes than
those found in the YU39 genome [58]. Further functional
analyses are necessary to address the impact of the pseu-
dogenes on the pathogenesis of strain 33676.
We agree with Davies and Davies [59], in that antibiotic
resistance can be considered as a marker concurrent with
virulence factors; as some MDR strains have also acquired
increased virulence and enhanced transmissibility [59].
Since many studies have addressed the importance of the
animal reservoirs in the spread of MDR Salmonella
throughout the food chain [2, 21, 60, 61], it is necessary to
make efforts to restart the epidemiological surveillance
program in Mexico to address the prevalence of ST213
strains, and the emergence of new variants, in the human
population and the animal-production settings.
Conclusion
In this study, a bacterial isolate that caused severe
gastrointestinal and systemic (bacteremia) infections in a
healthy young woman was characterized using a battery
of molecular tools. Two main features distinguished
strain 33676 from the originally described ST213 strains.
First, the blaCMY-2 gene was not carried on the IncA/C
plasmid, but on a conjugative IncF plasmid, which may
open a new route of dissemination for this ESC-
resistance gene. Second, strain 33676 expresses the H2
FljB flagella, in contrast with the other ST213 and most
Typhimurium reference strains. The expression of FljB,
instead FliC, probably does not determine the virulence
attenuation of the 33676 strain in mice, but it could be
relevant for infection to humans.
To our knowledge this is the first report of an IncF
blaCMY-2-carrying plasmid in Salmonella. Moreover, the
co-integration of the MDR IncA/C plasmid with the
conjugative IncF-blaCMY-2 carrying plasmid highlights
the plastic nature of the plasmid compartment of this
Typhimurium strain.
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Additional file 2 Figure S1. Strain 33676 belongs to the Mexican ST213
population. The dendrogram depicts the genetic relationships among
Mexican Typhimurium strains based on XbaI restrictions resolved by
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from culture supernatants was performed for strains SL1344, ΔSPI-1 and
YU39 grown in LB medium. TCA-precipitated proteins SipA, SipB, SipC
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secretion is independent of SPI-1. (PDF 118 kb)
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